Clover Health Investments Corp (NASDAQ: CLOV) kicked off on Monday, remained unchanged from the previous trading day, before settling in for the closing price of $2.51. Over the past 52 weeks, CLOV has traded in a range of $0.61-$3.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 52.25% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 71.35%. With a float of $375.64 million, this company’s outstanding shares have now reached $393.27 million.
In an organization with 552 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 18.33%, operating margin of -7.26%, and the pretax margin is -7.57%.
Clover Health Investments Corp (CLOV) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.49%, while institutional ownership is 14.74%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.09 earnings per share (EPS), higher than consensus estimate (set at -0.11) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Take a look at Clover Health Investments Corp’s (CLOV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Let’s dig in a bit further. During the last 5-days, its volume was 9.95 million. That was better than the volume of 8.07 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 9.70%. Additionally, its Average True Range was 0.28.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 59.33%, which indicates a significant increase from 4.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.96% in the past 14 days, which was higher than the 97.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.09, while its 200-day Moving Average is $1.21. However, in the short run, Clover Health Investments Corp’s stock first resistance to watch stands at $2.60. Second resistance stands at $2.69. The third major resistance level sits at $2.74. If the price goes on to break the first support level at $2.46, it is likely to go to the next support level at $2.41. Assuming the price breaks the second support level, the third support level stands at $2.32.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
The company with the Market Capitalisation of 1.25 billion has total of 496,437K Shares Outstanding. Its annual sales at the moment are 2,034 M in contrast with the sum of -213,360 K annual income. Company’s last quarter sales were recorded 356,260 K and last quarter income was 7,410 K.
